title: Low-dose administration of oral pazopanib for the treatment of recurrent angiosarcoma.
authors.affiliation: Department of Dermatology, Sakai City Hospital, 1-1-1 Minamiyasui-cho, Sakai City, Osaka, 590-0064, Japan. tori2@mac.com.
authors.forename: H
authors.initials: H
authors.lastname: Miura
authors.affiliation: Department of Dermatology, Sakai City Hospital, 1-1-1 Minamiyasui-cho, Sakai City, Osaka, 590-0064, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Shirai
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D005260:Female; D006394:Hemangiosarcoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007191:Indazoles; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013449:Sulfonamides / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D007191:Indazoles; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib